(Z)-6-[(2S,4S,5R)-2-(6-chloro-4-oxochromen-3-yl)-4-(2-hydroxyphenyl)-1,3-dioxan-5-yl]hex-4-enoic acid | 1040373-09-8

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 苯并吡喃
• 英文名称: (Z)-6-[(2S,4S,5R)-2-(6-chloro-4-oxochromen-3-yl)-4-(2-hydroxyphenyl)-1,3-dioxan-5-yl]hex-4-enoic acid
• CAS: 1040373-09-8
• 化学式: C₂₅H₂₃ClO₇
• 分子量: 470.906
• InChiKey: XITUCAXEDQSMKO-KUGPTZFMSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.8
• 重原子数：
  33
• 可旋转键数：
  7
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.28
• 拓扑面积：
  102
• 氢给体数：
  2
• 氢受体数：
  7

反应信息

• 作为产物：
  描述：

  4(Z)-6-(4-o-hydroxyphenyl-2,2-dimethyl-1,3-dioxan-cis-5-yl) hexenoic acid 在 对甲苯磺酸 作用下， 以 甲苯 为溶剂， 反应 24.0h， 生成 (Z)-6-[(2S,4S,5R)-2-(6-chloro-4-oxochromen-3-yl)-4-(2-hydroxyphenyl)-1,3-dioxan-5-yl]hex-4-enoic acid
  参考文献：
  名称：

  WO2008/89461

  摘要：

  公开号：

文献信息

• PPAR Modulators
  申请人：Evolva SA

  公开号：EP2363127A1

  公开（公告）日：2011-09-07

  1,3-dioxane derivatives and their use in the treatment of a disease or condition dependent on PPAR modulation, such as diabetes, cancer, inflammation, neurodegenerative disorders and infections.

  1,3-二恶烷衍生物及其在治疗依赖 PPAR 调节的疾病或病症（如糖尿病、癌症、炎症、神经退行性疾病和感染）中的用途。
• SUBSTITUTED 1,3-DIOXANES AND THEIR USES
  申请人：Sorensen Alexandra Santana

  公开号：US20100273824A1

  公开（公告）日：2010-10-28

  The present invention relates to compounds containing 1,3-dioxane moiety, pharmaceutical compositions thereof, and the use of the compounds and compositions for the modulation of thromboxane A2 or a peroxisome proliferator-activated receptor. The compounds, analogs, and pharmaceutically acceptable salts thereof, and pharmaceutical compositions can be used in the treatment and prevention of cancer.
• 1,3-Dioxanes and Their Uses
  申请人：Sorensen Alexandra Santana

  公开号：US20120252836A1

  公开（公告）日：2012-10-04

  The present invention relates to compounds containing 1,3-dioxane moiety, pharmaceutical compositions thereof, and the use of the compounds and compositions for the modulation of thromboxane A2 or a peroxisome proliferator-activated receptor. The compounds, analogs, and pharmaceutically acceptable salts thereof, and pharmaceutical compositions can be used in the treatment and prevention of cancer.
• Substituted 1,3-Dioxanes and There Uses
  申请人：Sorensen Alexandra Santana

  公开号：US20130197030A1

  公开（公告）日：2013-08-01

  The present invention relates to compounds containing 1,3-dioxane moiety, pharmaceutical compositions thereof, and the use of the compounds and compositions for the modulation of thromboxane A2 or a peroxisome proliferator-activated receptor. The compounds, analogs, and pharmaceutically acceptable salts thereof, and pharmaceutical compositions can be used in the treatment and prevention of cancer.
• [EN] SUBSTITUTED 1,3-DIOXANES AND THEIR USES<br/>[FR] 1,3-DIOXANES SUBSTITUÉS ET LEURS UTILISATIONS
  申请人：EVOLVA SA

  公开号：WO2008089463A2

  公开（公告）日：2008-07-24

  [EN] The present invention relates to compounds containing 1,3-dioxane moiety, pharmaceutical compositions thereof, and the use of the compounds and compositions for the modulation of thromboxane A2 or a peroxisome proliferator-activated receptor. The compounds, analogs, and pharmaceutically acceptable salts thereof, and pharmaceutical compositions can be used in the treatment and prevention of cancer.
  [FR] La présente invention concerne des composés contenant un groupe fonctionnel 1,3-dioxane, des compositions pharmaceutiques de ceux-ci, et l'utilisation des composés et des compositions pour moduler la modulation du hromboxane A2 et d'un récepteur activé par les proliférateurs de peroxysome. Les composés, des analogues, et des sels acceptables pharmaceutiquement de ceux-ci et les compositions pharmaceutiques peuvent être utilisés dans le traitement et la prévention de cancer.